Business Standard Article RatingDr. Reddy's, Shaily Engineering tumble after delay in Semaglutide approval
- Bias Rating
- Reliability
40% ReliableAverage
- Policy Leaning
N/A
- Politician Portrayal
N/A
Continue For Free
Create your free account to see the in-depth bias analytics and more.
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates.
Bias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Reliability Score Analysis
Policy Leaning Analysis
Politician Portrayal Analysis
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Contributing sentiments towards policy:
51% : Need for clarity on regulations in crypto sector, says Dilip Chenoy IOCL seeks up to 24 million oil barrels from Americas amid Russia curbs Stock Market LIVE: Sensex cracks 360pts, Nifty tests 25,900; Trump likely cuts China tariff to 47% The company also revealed plans to add another 25 million-pen line for a different Semaglutide variant, with a total capex of Rs 125 crore for FY26.*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.
